Financial Performance - The company's operating revenue for 2024 reached ¥504,617,322.62, representing a 1.88% increase compared to ¥495,286,440.12 in 2023[30]. - Net profit attributable to shareholders surged by 151.51% to ¥52,954,946.94 in 2024 from ¥21,054,499.99 in 2023[30]. - The net profit after deducting non-recurring gains and losses decreased by 47.63% to ¥60,420,228.72 in 2024 from ¥115,373,183.55 in 2023[30]. - The basic earnings per share increased by 158.00% to ¥0.2531 in 2024 from ¥0.0981 in 2023[30]. - The total assets at the end of 2024 were ¥2,218,238,761.93, a decrease of 9.51% from ¥2,451,410,876.03 at the end of 2023[30]. - The net assets attributable to shareholders decreased by 4.75% to ¥1,927,737,690.83 at the end of 2024 from ¥2,023,840,457.76 at the end of 2023[30]. - The cash flow from operating activities showed a significant decline, with a net outflow of ¥77,323,208.77 in 2024 compared to a net inflow of ¥13,975,199.53 in 2023, marking a 653.29% decrease[30]. - The company reported a quarterly revenue of ¥131,860,484.39 in Q4 2024, with a net profit attributable to shareholders of -¥14,332,279.21[32]. - Non-recurring losses totaled -7,465,281.78 CNY in 2024, a significant decrease from -94,318,683.56 CNY in 2023, while the government subsidies recognized increased to 8,082,956.28 CNY from 2,631,248.86 CNY[36]. - The total distributable profit for the reporting period is 389,187,673.74 yuan, indicating a strong financial position[167]. Dividend Distribution - The company plans to distribute a cash dividend of 1.5 RMB per 10 shares to all shareholders, based on a total share count of 205,350,882 shares as of December 31, 2024[13]. - Total cash dividends, including other methods, amount to 149,718,632.3 yuan, representing 100% of the distributable profit[167]. - The company has not proposed any stock bonus or capital reserve conversion during the reporting period, maintaining a focus on cash dividends[166]. Industry Overview - The fine chemical industry in China achieved a total output value of 15.3 trillion CNY in 2024, representing a year-on-year growth of 7.8%[40]. - The fine chemical market size reached 4.5 trillion CNY in 2024, with a year-on-year increase of 9.1%, driven by rising demand for high-value products like cosmetics and pharmaceutical intermediates[40]. - The fine chemical industry is projected to see a production value growth rate of 15%-20% for specialty chemicals, driven by high-end manufacturing needs[40]. - The company anticipates that the fine chemical industry will enter a new growth cycle driven by "green, high-end, and intelligent" trends by 2025[41]. - The government is expected to implement more proactive fiscal policies and moderately loose monetary policies to stimulate domestic demand, supporting stable industry operations in 2025[43]. Environmental Management - The company is committed to green production practices and has made efforts to reduce pollutant emissions throughout its operations[5]. - The company acknowledges the potential impact of environmental pollution incidents on its operations and financial performance[6]. - The company has implemented strict environmental protection measures but may face increased costs due to evolving regulations and standards[6]. - The company has established a pollution discharge permit valid until July 26, 2028, for its main operations[183]. - The company is classified as a key pollutant discharge unit by environmental protection authorities[183]. - The company reported a total COD discharge of 12.9 tons, with no exceedance of discharge standards[183]. - The company has established a wastewater treatment facility that meets the discharge standards for the Qishan Industrial Park[185]. - The company has implemented measures to reduce carbon emissions, including energy-saving modifications and employee training on environmental awareness[199]. Research and Development - The company has developed a core technology system through years of research and development, positioning itself at the forefront of the industry[8]. - The company has a research and development team of 84 personnel, ensuring continuous innovation and high-quality production processes[53]. - The total R&D investment amounted to ¥29,003,432.45, representing 5.75% of total revenue, an increase from 5.23% in the previous year[75]. - The company has developed proprietary technologies for the continuous production of 2-chloropyridine, enhancing production efficiency[49]. - The company has a total of 41 patents, including 18 invention patents and 23 utility model patents, demonstrating its strong focus on innovation[53]. Risk Management - The company faces risks related to raw material price fluctuations, which could significantly impact profitability if not managed effectively[4]. - The company faces risks related to product price fluctuations due to raw material costs and market competition, which could significantly impact profitability if not managed properly[106]. - Environmental protection risks are present due to the nature of the chemical industry, and the company has implemented measures to reduce emissions and comply with regulations[107]. - The company has established a clear strategy for risk management in its investment activities, focusing on low to medium-risk financial products[112]. Governance and Management - The company has established a comprehensive internal control system to manage risks and ensure compliance with relevant laws and regulations[122]. - The company has a robust governance structure that includes a general meeting of shareholders, a board of directors, and a supervisory board, ensuring legal compliance and protection of shareholder rights[117]. - The board of directors consists of 9 members, complying with legal and regulatory requirements, and includes specialized committees for strategic decision-making[119]. - The company maintains independence from its controlling shareholders in terms of operations, personnel, assets, and finances, ensuring autonomous business capabilities[126]. - The company has a diverse management team with backgrounds in finance, law, and chemical engineering, enhancing its operational capabilities[143]. Employee Management - The total number of employees at the end of the reporting period is 700, with 601 in the parent company and 99 in major subsidiaries[162]. - The professional composition includes 406 production personnel, 20 sales personnel, 173 technical personnel, 13 financial personnel, and 88 administrative personnel[162]. - The company has implemented a training program for employees, focusing on safety education and professional qualifications, enhancing workforce competency[171]. - The company emphasizes safety, environmental protection, and occupational health, maintaining compliance with national regulations and conducting regular training[173]. Safety Management - The company has not experienced any major safety production accidents since its establishment, highlighting its commitment to safety management[7]. - The company emphasizes safety production and has established strict management systems to mitigate risks associated with hazardous materials used in production[108]. - The company has received various safety and hazardous chemical operation permits, ensuring compliance with regulatory standards[51].

Financial Performance - The company's revenue for Q1 2025 was ¥127,745,007.11, representing a 22.79% increase compared to ¥104,036,675.03 in the same period last year[5] - Net profit attributable to shareholders decreased by 9.72% to ¥16,775,409.00 from ¥18,581,100.08 year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥16,521,640.45, down 14.58% from ¥19,342,277.26 in the previous year[5] - Basic and diluted earnings per share were both ¥0.0800, down 7.62% from ¥0.0866 year-on-year[5] - Net profit for the period was ¥16,775,409.00, down from ¥18,581,100.08, indicating a decrease of about 9.6% year-over-year[18] - Basic and diluted earnings per share decreased to ¥0.0800 from ¥0.0866, reflecting a decline of approximately 9.6%[18] Cash Flow and Liquidity - The net cash flow from operating activities was -¥56,155,239.27, a decline of 7.47% compared to -¥52,251,582.07 in the same period last year[5] - Cash flow from operating activities showed a net outflow of ¥56,155,239.27, compared to a net outflow of ¥52,251,582.07 in the previous period[21] - Cash and cash equivalents at the end of the period decreased to ¥177,928,607.04 from ¥567,572,432.75, a decline of approximately 68.7%[22] - Current cash and cash equivalents decreased to ¥886,935,613.81 from ¥1,063,865,186.11, reflecting a decline of 16.6%[12] - Investment activities resulted in a net cash outflow of ¥80,387,951.48, compared to a net outflow of ¥42,767,432.75 in the previous period, indicating increased investment expenditures[21] - Financing activities generated a net cash outflow of ¥63,111,098.00, compared to a net outflow of ¥18,128,600.13 in the previous period, reflecting higher debt repayments[21] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,115,703,049.13, a decrease of 4.62% from ¥2,218,238,761.93 at the end of the previous year[5] - Total assets amounted to ¥2,115,703,049.13, down from ¥2,218,238,761.93, indicating a decrease of 4.6%[14] - Total liabilities decreased to ¥195,725,944.85 from ¥290,501,071.10, a reduction of 32.6%[14] - The company's total equity attributable to shareholders was ¥1,919,977,104.28, slightly down from ¥1,927,737,690.83, a decrease of 0.9%[14] - Shareholders' equity attributable to the parent company was ¥1,919,977,104.28, down 0.40% from ¥1,927,737,690.83 at the end of the previous year[5] Operational Metrics - Total operating revenue for the current period reached ¥127,745,007.11, an increase of 22.9% compared to ¥104,036,675.03 in the previous period[16] - Total operating costs increased to ¥107,443,402.72 from ¥80,775,190.46, representing a growth of approximately 33%[17] - Accounts receivable increased to ¥21,666,584.78 from ¥7,285,155.00, showing a significant rise of 197.5%[13] - Inventory rose to ¥87,322,462.99 from ¥76,786,648.82, reflecting an increase of 13.4%[13] - Contract liabilities increased to ¥4,542,796.73 from ¥2,118,010.11, a growth of 114.0%[14] Other Income and Expenses - The company reported a non-operating income of ¥1,539,559.32 from government subsidies, which are closely related to normal business operations[6] - Other income increased significantly to ¥1,539,559.32 from ¥235,699.48, showing a growth of approximately 553%[17] - Research and development expenses rose to ¥4,751,721.12 from ¥3,999,460.52, an increase of approximately 18.8%[17] - Tax expenses decreased to ¥3,000,629.22 from ¥3,695,126.68, a reduction of about 18.8%[17] Shareholder Information - The total number of common shareholders at the end of the reporting period was 14,948[9] - The largest shareholder, Huang Guorong, holds 18.64% of the shares, amounting to 40,000,000 shares[9]

化工股再度活跃，善水科技（301190）涨停，红宝丽（002165）涨超9%，渤海化学（600800）、怡达 股份（300721）、中毅达（600610）、红墙股份（002809）等跟涨。 暗盘资金正涌入这些股票，点击速看>>> ...

九江善水科技股份有限公司 关于股份回购进展暨回购完成的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 九江善水科技股份有限公司（以下简称"公司"）于 2024 年 7 月 22 日 召开第三届董事会第九次会议，审议通过了《<关于以集中竞价交易方式回购股 份方案>的议案》，同意使用自有资金通过集中竞价交易方式回购公司股份，用 于实施员工持股计划或股权激励。回购股份的资金总额不低于人民币 5,000.00 万元（含本数）且不超过人民币 10,000.00 万元（含本数），具体回购资金总额 以回购期满时实际回购股份使用的资金总额为准；回购价格不超过人民币 20.68 元/股（含本数）。回购股份的实施期限自公司董事会审议通过回购方案之日起 不超过 12 个月。具体内容详见公司在巨潮资讯网（www.cninfo.com.cn）上披露 的相关公告。 截至本公告披露日，公司上述回购股份方案已实施完毕，根据《上市公司股 份回购规则》、《深圳证券交易所上市公司自律监管指引第 9 号——回购股份》 等 相关规定，现将本次回购的有关事项公告如下： 一、本次回购公司股份的进展情 ...

证券代码：301190 证券简称：善水科技 公告编号：2025-005 九江善水科技股份有限公司 关于股份回购进展情况的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 九江善水科技股份有限公司（以下简称"公司"）于 2024 年 7 月 22 日 召开第三届董事会第九次会议，审议通过了《<关于以集中竞价交易方式回购股 份方案>的议案》，同意使用自有资金通过集中竞价交易方式回购公司股份，用 于实施员工持股计划或股权激励。回购股份的资金总额不低于人民币 5,000.00 万元（含本数）且不超过人民币 10,000.00 万元（含本数），具体回购资金总额 以回购期满时实际回购股份使用的资金总额为准；回购价格不超过人民币 20.68 元/股（含本数）。回购股份的实施期限自公司董事会审议通过回购方案之日起 不超过 12 个月。具体内容详见公司在巨潮资讯网（www.cninfo.com.cn）上披露 的相关公告。 根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9 号--回购股份》等相关规定，回购期间内，公司应当在每个月的前三个交易日 内公告截至 ...

证券代码：301190 证券简称：善水科技 公告编号：2025-004 （1）自可能对本公司股票交易价格产生重大影响的重大事项发生之日或者 在决策过程中，至依法披露之日内； 九江善水科技股份有限公司 关于股份回购进展情况的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 九江善水科技股份有限公司（以下简称"公司"）于 2024 年 7 月 22 日 召开第三届董事会第九次会议，审议通过了《<关于以集中竞价交易方式回购股 份方案>的议案》，同意使用自有资金通过集中竞价交易方式回购公司股份，用 于实施员工持股计划或股权激励。回购股份的资金总额不低于人民币 5,000.00 万元（含本数）且不超过人民币 10,000.00 万元（含本数），具体回购资金总额 以回购期满时实际回购股份使用的资金总额为准；回购价格不超过人民币 20.68 元/股（含本数）。回购股份的实施期限自公司董事会审议通过回购方案之日起 不超过 12 个月。具体内容详见公司在巨潮资讯网（www.cninfo.com.cn）上披露 的相关公告。 根据《上市公司股份回购规则》《深圳证券交易所上市公司 ...

Profit Projections - The estimated net profit attributable to shareholders for 2024 is projected to be between 52 million and 68 million CNY, representing a year-on-year increase of 146.98% to 222.97% compared to 21.05 million CNY in the previous year[3]. - The net profit after deducting non-recurring gains and losses is expected to be between 52 million and 68 million CNY, which indicates a decline of 41.06% to 54.93% from 115.37 million CNY in the same period last year[3]. Factors Influencing Profit - The increase in net profit is primarily due to significant losses from fair value changes of trading financial assets recognized in the previous year[5]. - The decrease in net profit after deducting non-recurring gains is attributed to increased fixed costs during the trial production period of investment projects and a decline in interest income due to lower deposit rates[6]. Reporting Timeline - The specific data for the 2024 annual performance will be disclosed in the company's annual report[7].

二、其他说明 （一）公司回购股份的时间、回购股份数量、回购股份价格及集中竞价交易 委托时段符合《深圳证券交易所上市公司自律监管指引第 9 号--回购股份》相关 规定。 1、公司未在下列期间内回购股份： 证券代码：301190 证券简称：善水科技 公告编号：2025-002 九江善水科技股份有限公司 关于回购公司股份达到 1%暨回购进展的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 九江善水科技股份有限公司（以下简称"公司"）于 2024 年 7 月 22 日 召开第三届董事会第九次会议，审议通过了《<关于以集中竞价交易方式回购股 份方案>的议案》，同意使用自有资金通过集中竞价交易方式回购公司股份，用 于实施员工持股计划或股权激励。回购股份的资金总额不低于人民币 5,000.00 万元（含本数）且不超过人民币 10,000.00 万元（含本数），具体回购资金总额 以回购期满时实际回购股份使用的资金总额为准；回购价格不超过人民币 20.68 元/股（含本数）。回购股份的实施期限自公司董事会审议通过回购方案之日起 不超过 12 个月。具体内容详见公司在巨潮资 ...

证券代码：301190 证券简称：善水科技 公告编号：2024-060 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 | 彭泽支行 | 存款 | 利率 | 集资金 | | --- | --- | --- | --- | | | | 型 | | | 二、使用闲置募集资金购买现金管理产品的情况 | | --- | | 序 | 受托方 | 产品 | 产品 | 金额 | 产品 | 产品 | 预计年 | 资金来 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | | 名称 | 类型 | （万 | 起息日 | 到期日 | 化收益 | 源 | | | | | | 元） | | | 率 | | | 1 | 九江银行 | 定期 | 固定 | 55,000 | 2024/12/2 | 2025/12/23 | 1.75% | 闲置募 | | | 彭泽支行 | 存款 | 利率 | | 3 | | | 集资金 | | | | | 型 | | | | | | 关于使用部分闲置募集资金进行现金管理的进展公告 九 ...